Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | lapuleucel-T |
Synonyms | |
Therapy Description |
Neuvenge (lapuleucel-T) is a cellular vaccine of antigen-presenting cells cultured with recombinant Erbb2 (Her2) antigen linked to GMCSF, which stimulates anti-tumor response against Erbb2 (Her2) expressing tumor cells (J Clin Oncol 34, 2016 (suppl; abstr 4513), PMID: 19723649). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
lapuleucel-T | Neuvenge|APC8024|DN24-02 | Neuvenge (lapuleucel-T) is a cellular vaccine of antigen-presenting cells cultured with recombinant Erbb2 (Her2) antigen linked to GMCSF, which stimulates anti-tumor response against Erbb2 (Her2) expressing tumor cells (J Clin Oncol 34, 2016 (suppl; abstr 4513), PMID: 19723649). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|